Search

Your search keyword '"Martins, Ronaldo B"' showing total 47 results

Search Constraints

Start Over You searched for: Author "Martins, Ronaldo B" Remove constraint Author: "Martins, Ronaldo B"
47 results on '"Martins, Ronaldo B"'

Search Results

1. Efferocytosis of SARS-CoV-2-infected dying cells impairs macrophage anti-inflammatory functions and clearance of apoptotic cells

2. Gasdermin-D activation by SARS-CoV-2 triggers NET and mediate COVID-19 immunopathology

3. Cardiovascular and kidney diseases are positively associated with neuroinflammation and reduced brain-derived neurotrophic factor in patients with severe COVID-19

4. A mimetic peptide of ACE2 protects against SARS-CoV-2 infection and decreases pulmonary inflammation related to COVID-19

5. SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients

6. Enoxaparin improves COVID-19 by reducing Neutrophils Extracellular Traps (NETs) production

7. Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients

8. Pulmonary inflammation and viral replication define distinct clinical outcomes in fatal cases of COVID-19

9. Mitochondrial DNA and TLR9 activation contribute to SARS-CoV-2-induced endothelial cell damage

11. The use of denaturing solution as collection and transport media to improve SARS-CoV-2 RNA detection and reduce infection of laboratory personnel

12. Cytokine storm in individuals with severe COVID-19 decreases endothelial cell antioxidant defense via downregulation of the Nrf2 transcriptional factor

14. CASP4/11 Contributes to NLRP3 Activation and COVID-19 Exacerbation

15. TONSILS ARE MAJOR SITES OF PROLONGED SARS-COV-2 INFECTION IN CHILDREN

16. Asymptomatic SARS-COV-2 infection in children's tonsils

17. Mast cell-T cell axis alters development of colitis-dependent and colitis-independent colorectal tumours: potential for therapeutically targeting via mast cell inhibition

18. Identification of immunomodulatory drugs that inhibit multiple inflammasomes and impair SARS-CoV-2 infection

20. Celastrol: A lead compound that inhibits SARS‐CoV‐2 replication, the activity of viral and human cysteine proteases, and virus‐induced IL‐6 secretion

21. Morphological, cellular, and molecular basis of brain infection in COVID-19 patients

22. Inflammasome activation and pulmonary viral loads define two distinct clinical outcomes in COVID-19

23. Efferocytosis of SARS-CoV-2-infected dying cells impairs macrophage anti-inflammatory functions and clearance of apoptotic cells

24. Author response: Efferocytosis of SARS-CoV-2-infected dying cells impairs macrophage anti-inflammatory functions and clearance of apoptotic cells

25. Additional file 1 of Gasdermin-D activation by SARS-CoV-2 triggers NET and mediate COVID-19 immunopathology

26. Gasdermin-D activation by SARS-CoV-2 trigger NET and mediate COVID-19 immunopathology

27. Enoxaparin Improves COVID-19 by Reducing Neutrophils Extracellular Traps (NETS) Production

28. COVID‐19 bimodal clinical and pathological phenotypes

29. COVID-19 Bimodal Clinical and Pathological Phenotypes

30. Detection of respiratory viruses in primary cholesteatoma tissues

31. Efferocytosis of SARS-CoV-2-infected dying cells impairs macrophage antiinflammatory functions and clearance of apoptotic cells.

32. Drug repurposing to face Covid-19: Celastrol, a potential leading drug capable of inhibiting SARS-CoV-2 replication and induced inflammation

33. Efferocytosis of SARS-CoV-2-infected dying cells impairs macrophage anti-inflammatory functions and clearance of apoptotic cells

34. Matrix Metalloproteinases on Severe COVID-19 Lung Disease Pathogenesis: Cooperative Actions of MMP-8/MMP-2 Axis on Immune Response through HLA-G Shedding and Oxidative Stress.

35. Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients

37. Inflammasome activation in COVID-19 patients

38. Infection of human lymphomononuclear cells by SARS-CoV-2

39. Silent Infection of B and CD8 + T Lymphocytes by Influenza A Virus in Children with Tonsillar Hypertrophy

41. Serotonin synthesis protects the mouse colonic crypt from DNA damage and colorectal tumorigenesis

42. SARS-CoV-2 Inactivation by Ozonated Water: A Preliminary Alternative for Environmental Disinfection.

43. Oropouche virus is detected in peripheral blood leukocytes from patients

45. Silent infection of B and CD8+ T lymphocytes by influenza A virus in children with tonsillar hypertrophy.

46. Cytokine storm in individuals with severe COVID-19 decreases endothelial cell antioxidant defense via downregulation of the Nrf2 transcriptional factor.

47. Infection of human lymphomononuclear cells by SARS-CoV-2.

Catalog

Books, media, physical & digital resources